Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G CEO Lafley Could Follow Divested Brands Out The Door

This article was originally published in The Tan Sheet

Executive Summary

A.G. Lafley is expected to remain P&G chairman after stepping down as CEO as soon as this summer, according to recent reports.

You may also be interested in...



In Brief

P&G’s Wella hair-care unit is on the auction block reportedly, with Henkel, Kao and Unilever among potential buyers. More news in brief.

Slimmed-Down P&G To Consist Of 65 ‘Leading Brands’ By FY 2017

At the CAGNY conference Feb. 19, P&G leadership provided new insight into the company’s streamlining program, specifically where the firm will end up after selling off 100 underperforming brands in deals expected to be closed by June 30, 2016. CFO Jon Moeller listed Gillette, Pantene, Head & Shoulders and Olay among core brands that will emerge from the simplification, highlighting recent innovations and marketing initiatives that are resonating with its core audience and driving growth.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107624

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel